Edward Larry Mccleary, MD | |
481 Alpine View Dr, Incline Village, NV 89451-8916 | |
(720) 840-6528 | |
Not Available |
Full Name | Edward Larry Mccleary |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 481 Alpine View Dr, Incline Village, Nevada |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396989745 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 27292 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Edward Larry Mccleary, MD 481 Alpine View Dr, Incline Village, NV 89451-8916 Ph: (720) 840-6528 | Edward Larry Mccleary, MD 481 Alpine View Dr, Incline Village, NV 89451-8916 Ph: (720) 840-6528 |
News Archive
Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.
Researchers have identified two genetic signatures for castration-resistant prostate cancer that may predict the severity of the disease.
The global economy has affected HIV/AIDS prevention research, so "scientists and those who fund them are struggling to set priorities among several competing research methods that could slow the spread of the disease, which causes about 2.7 million new infections worldwide a year," CQ HealthBeat reports.
Researchers funded by Fight for Sight, in partnership with The Spectacle Makers' Charity and Glaucoma UK, are investigating if a naturally occuring protein in the body can be used to prevent sight loss from glaucoma.
› Verified 3 days ago